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ABSTRACT
Objective: The objective of this study was to analyze demographics, management pattern, and clinical outcomes in patients with organophosphorus 
poisoning.
Methods: In this subgroup analysis of retrospective data of patients admitted in intensive care unit (ICU) with a diagnosis of acute organophosphorus 
poisoning, demographic details, pattern of use of medicines, dose of atropine and pralidoxime (PRAM), duration of ICU stay, and clinical outcomes 
were analyzed.
Results: A total of 92 patients with organophosphorus poisoning (mean age 34.7 years; male 69 [75%]) were included. The age of male patients was 
more than female patients (36.2 vs. 30.0 years; p=0.047). Atropine and PRAM were given to all patients. Ondansetron was used in all patients, whereas 
ranitidine was used in 91 (98.9%) patients. The mean total dose of atropine in male and female population was 99.5 mg and 89.0 mg, respectively 
(p=0.298). The mean total dose of PRAM in male and female population was 12.2 mg and 12.0 mg, respectively (p=0.772). There was no difference 
in the mean (standard deviation) duration of stay in ICU between male patients and female patients (7.6 [4.5] vs. 6.4 [3.9] days; p=0.249). A total of 
61 (66.3%) patients were transferred to the ward, whereas 30 (32.6%) died.
Conclusion: Atropine and PRAM are the primary drugs for the treatment of organophosphorus poisoning. Ondansetron and ranitidine are useful 
drugs for the treatment of vomiting and gastric irritation, respectively, in these patients.
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INTRODUCTION
Acute poisoning with organophosphorus compounds is one of the major 
concerns, especially in developing countries [1] including India [2-4] 
because of its high mortality rate [2,3]. A study from India has reported 
a mortality rate of 22.6% among hospitalized patients with pesticide 
poisoning [5].
Organophosphorus poisoning is not a single entity [6]. Organophosphorus 
compounds are the group of compounds with strong anticholinesterase 
activity. These are often used as insecticides and pesticides [7].
The symptoms of organophosphorus poisoning include those because 
of muscarinic and nicotinic receptor stimulation [7]. Patients with 
organophosphorus poisoning often require admission in the intensive 
care unit (ICU) [8]. The goals of the treatment of acute organophosphorus 
poisoning include limiting absorption of the toxin, increasing excretion 
of poison, and neutralizing the effects of organophosphorus compound 
by giving antagonist [9].
Overall treatment strategy of acute organophosphorus poisoning 
includes resuscitation, oxygen, intravenous fluids, antimuscarinic 
agent, acetylcholinesterase reactivator, and gastric lavage [10]. 
Atropine, a muscarinic antagonistic, is a mainstay of treatment in acute 
organophosphorus poisoning [9]. Pralidoxime (PRAM) is another 
important compound in the treatment of acute organophosphorus 
poisoning [3].
Although poisoning with organophosphorus compounds is common, 
there are no large, systematic epidemiological studies from India [7]. 
Similarly, there are limited pharmacoepidemiological data related to 
organophosphorus compound poisoning from Maharashtra.
Objective
The objective of this study was to analyze demographics, management 
pattern, and clinical outcomes of patients with organophosphorus 
poisoning admitted in the medical ICU.
METHODS
Recently, a retrospective study among patients admitted in medical 
ICU with a diagnosis of acute poisoning was published [11]. In this 
article, we analyzed the subgroup of patients with organophosphorus 
poisoning admitted in medicine ICU from January 2017 to July 2017. 
Demographic details (age and gender) were collected. Different 
medicines used for the treatment of organophosphorus poisoning, 
dose of atropine, and PRAM were calculated. The difference in the 
dosage of these two medicines was analyzed. Duration of ICU stay 
was calculated. Clinical outcomes of male and female patients were 
compared. Approval from the institutional ethics committee was 
taken for the main study. As this is a subgroup analysis of larger data 
set, a separate approval from ethics committee was not obtained.
Statistical analysis
Continuous data are presented as mean and standard deviation (SD), 
whereas categorical data are presented as number and percentages. 
Unpaired t-test was used to compare the difference in the means 
between two groups. Categorical data were compared using Chi-square 
test. p<0.05 was considered as statistically significant.
RESULTS
A total of 92 patients with organophosphorus poisoning were included 
in this study. The mean age of patients in the study was 34.7 years. 
The study population was predominated by male population (75% vs. 
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25%). There was a significant difference in the age of male and female 
patients (36.2 vs. 30.0 years; p=0.047; Table 1).
Table 2 shows a list of medicines used in the treatment of patients 
with organophosphorus poisoning. The drugs were classified into four 
types based on their usage; those used as primary treatment, drugs 
for gastrointestinal disturbances, antimicrobial agents, and hypnotic/
sedatives. Primary treatment in the form of atropine and PRAM was 
given to all patients with organophosphorus poisoning. Drugs used for 
the treatment of gastrointestinal disturbances included ondansetron 
and ranitidine. Ondansetron was used in all patients, whereas ranitidine 
was used in 91 (98.9%) patients. The antimicrobial agents used in 
patients with organophosphorus poisoning included ceftriaxone 
(70.7%), metronidazole (29.3%), cefotaxime (28.3%), amoxicillin-
clavulanic acid (23.9%), amikacin (4.4%), meropenem (3.3%), and 
piperacillin plus tazobactam combination (3.3%). Hypnotic/sedatives 
used were midazolam (20.7%) and lorazepam (7.6%).
The mean total dose of atropine used in overall patient population, male 
population, and female population was 96.8, 99.5, and 89.0 mg, respectively 
(Table 3). There was no difference in the dose of atropine between male 
and female patients with organophosphorus poisoning (p=0.298). The 
mean total dose of PRAM in overall patient population, male population, 
and female population was 12.1, 12.2, and 12.0 mg, respectively (Table 3). 
There was no difference in the dose of PRAM between male and female 
patients with organophosphorus poisoning (p=0.772).
The mean (SD) duration of stay in ICU for overall patient population, 
male patients, and female patients was 7.3 (4.7), 7.6 (4.5), and 6.4 (3.9), 
respectively (Fig. 1). There was no difference in the duration of hospital 
stay between male and female patients (p=0.249).
A total of 61 (66.3%) patients were transferred to the ward, whereas 
30 (32.6%) died. One patient was discharged against medical advice 
(Table 4). There was no significant difference in male and female 
patients in terms of a number of patients transferred to the ward and 
those died (p=0.765).
DISCUSSION
Acute poisoning is an important cause of hospitalization [12,13]. Self-
poisoning with pesticides is a concern, especially in rural areas, because 
of easy access to toxic pesticides [14] and high rate mortality [15].
Unlike a study from Nepal [2], in our study, male population was more 
affected because of organophosphorus poisoning. Our results are 
similar to other studies from India [16-18], showing more occurrence 
of poisoning in male population compared to female population. As 
reported in other studies [2,16], people from working population 
were more commonly affected in our study too. The results of our 
study suggest that working male population is more affected by 
organophosphorus poisoning. We did not record the occupation and 
marital status of people affected, but it may have some association with 
organophosphorus poisoning [2].
Mortality in acute organophosphorus poisoning is usually because of 
respiratory failure and cardiovascular collapse due to cholinergic effects 
of the poison [19]. Atropine is an essential medicine for the treatment of 
organophosphorus poisoning. Serious cases cannot be managed without 
atropine [14]. Atropine remains the choice of drug for the management 
of cholinergic crisis in acute organophosphorus poisoning [3]. However, 
there are variations in the recommendations for atropinization [19]. 
Table 1: Baseline characteristics of study population (n=92)
Characteristics Result
Mean (SD) age 34.7 (13.1) years
Mean (SD) age of male patients 36.2 (13.1) years
Mean (SD) age of female patients 30.0 (12.3) years
Male, n (%) 69 (75)
Female, n (%) 23 (25)
SD: Standard deviation














Amoxycillin-clavulanic acid 22 (23.9)
Amikacin 4 (4.4)
Meropenem 3 (3.3)





Table 3: Total dose of atropine and PRAM used in patients with 
organophosphorus poisoning






Overall patient population (n=92) 96.8 (41.5) 12.1 (3.3)
Male patients (n=69) 99.5 (41.5) 12.2 (3.4)
Female patients (n=23) 89.0 (41.2) 12.0 (3.0)
PRAM: Pralidoxime
Fig. 1: Mean duration in intensive care unit stay of patients with 
organophosphorus poisoning
Table 4: Outcomes of patients with organophosphorus 
poisoning






Transferred to the 
ward
61 (66.3) 45 (65.2) 16 (69.6)
Mortality 30 (32.6) 23 (33.3) 7 (30.4)
Discharged against 
medical advice
1 (1.1) 1 (1.5) 0
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Glycopyrrolate is another anticholinergic drug that can be used for the 
treatment of organophosphorus poisoning [20]. In our study, all patients 
received atropine. In other studies too, all patients received atropine [18]. 
The mean total dose of atropine used in our study was 96.8 mg.
Atropine is ineffective at the nicotine-sensitive synapses. Reactivation 
of inhibited cholinesterase may be beneficial at both muscarinic and 
nicotinic receptors [21]. PRAM helps in restoring phosphorylated 
cholinesterase enzyme which is significantly inhibited in patients with 
organophosphorus poisoning. PRAM is useful for improving symptoms 
of muscle weakness and fasciculations [3]. In our study, all patients 
were treated with PRAM. High dose of PRAM has been shown to be 
associated with better survival as compared with lower dose [3]. In our 
study, mean total dose of PRAM used was 12.1 g. The requirement of 
PRAM in our study was similar to another study [20]. We did not find a 
significant difference in the dosing requirement of atropine and PRAM 
in male and female patients.
More than 5 days of stay in the hospital is common for patients with 
organophosphorus compound poisoning [16]. In our study, the mean 
duration of stay in ICU was 7.3 days. Our observation regarding hospital 
stay is similar to that reported by Kumar et al. [18].
Mortality rate due to organophosphorus poisoning in our study was 
similar to that of reported in another study from Gujarat [16].
Our study provides significant insights in terms of gender-wise 
comparison of characteristics in patients with organophosphorus 
poisoning. The results of our study underline the need and importance 
of education of the working population regarding harmful effects 
of organophosphorus compounds. Education and awareness may 
help to reduce the morbidity and mortality associated with acute 
organophosphorus poisoning.
Limitations of our study include retrospective study design, single-
center study, and small sample size. Considering these limitations, the 
results of our study should be carefully interpreted and extrapolated.
CONCLUSION
Atropine and PRAM are the primary drugs used in the treatment of 
organophosphorus poisoning. There is no difference in the mean total 
dosage of these drugs and duration of stay in ICU between male and 
female population. Ondansetron and ranitidine are useful drugs for the 
treatment of vomiting and gastric irritation, respectively, in these patients.
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